Schedule 13G ownership disclosure

MAST THERAPEUTICS INC

Security class unavailable · CUSIP: 576314108

Event date: 2016-02-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
12,887,614
Percent of class
6.6900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-16-000140
Form type
SC 13G
Filer
Savara Inc
CIK
CIK 1160308
Filed
Feb 12, 2016
Reporting period
Feb 10, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub